Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes

致病性 LMNA 变异会破坏心脏层-染色质相互作用并解除替代命运基因的抑制

阅读:7
作者:Parisha P Shah, Wenjian Lv, Joshua H Rhoades, Andrey Poleshko, Deepti Abbey, Matthew A Caporizzo, Ricardo Linares-Saldana, Julie G Heffler, Nazish Sayed, Dilip Thomas, Qiaohong Wang, Liam J Stanton, Kenneth Bedi, Michael P Morley, Thomas P Cappola, Anjali T Owens, Kenneth B Margulies, David B Frank,

Abstract

Pathogenic mutations in LAMIN A/C (LMNA) cause abnormal nuclear structure and laminopathies. These diseases have myriad tissue-specific phenotypes, including dilated cardiomyopathy (DCM), but how LMNA mutations result in tissue-restricted disease phenotypes remains unclear. We introduced LMNA mutations from individuals with DCM into human induced pluripotent stem cells (hiPSCs) and found that hiPSC-derived cardiomyocytes, in contrast to hepatocytes or adipocytes, exhibit aberrant nuclear morphology and specific disruptions in peripheral chromatin. Disrupted regions were enriched for transcriptionally active genes and regions with lower LAMIN B1 contact frequency. The lamina-chromatin interactions disrupted in mutant cardiomyocytes were enriched for genes associated with non-myocyte lineages and correlated with higher expression of those genes. Myocardium from individuals with LMNA variants similarly showed aberrant expression of non-myocyte pathways. We propose that the lamina network safeguards cellular identity and that pathogenic LMNA variants disrupt peripheral chromatin with specific epigenetic and molecular characteristics, causing misexpression of genes normally expressed in other cell types.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。